C.Serrano-PozoA.et al
If the hospital disclosed the payer-specific negotiated charge for an MS-DRG as a dollar amount, the hospital would use the dollar amount disclosed on its MRF under 45 CFR 180.50(b)(2)(ii)(C) in determining the median of the payer-specific negotiated charges to be reported on its Medicare cost report, as discussed further in section XX.C.2 of this final rule with comment period
GLP-1 receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, obesity
Ini merupakan penyakit yang bisa memengaruhi saraf, yang ditandai dengan muncul tremor dan kekakuan pada tubuh pengidapnya
Often referred to as the body's master antioxidant, glutathione plays a vital role in various physiological processes
CrossRef Short Communication Drug/Regimen Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study Hwi Seung Kim, Taekwan Yoon, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee Diabetes Metab J